Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRPL57 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | LYL1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | SLC16A6 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | CPA2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | GTF3C4 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | PCGF3 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | ZFYVE19 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | TAPBPL | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | AKT1S1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |